Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-HRSV G/Major surface glycoprotein G Antibody (CB002.5)

Catalog #:   VVV08501 Specific References (38) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: ELISA, Neutralization, WB
Accession: P27025
Overview

Catalog No.

VVV08501

Species reactivity

Human respiratory syncytial virus A (strain rsb6256)

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

Major surface glycoprotein G, Attachment glycoprotein G, Membrane-bound glycoprotein, mG, Mature secreted glycoprotein G, Mature sG, G

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P27025

Applications

ELISA, Neutralization, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

CB002.5

Data Image
  • Bioactivity
    Detects Human respiratory syncytial virus A (strain Long) G/Major surface glycoprotein G in indirect ELISAs.
References

Enhanced Pathogenic Consequences Induced by a Seven-Amino-Acid Extension in the G Protein of the HRSV BA9 Genotype., PMID:40076707

Benzimidazole analogs inhibit respiratory syncytial virus G protein function., PMID:26116756

Identification of a novel virulence factor in recombinant pneumonia virus of mice., PMID:17567693

C-terminal phosphorylation of human respiratory syncytial virus P protein occurs mainly at serine residue 232., PMID:7844563

A New Derivative of Retro-2 Displays Antiviral Activity against Respiratory Syncytial Virus., PMID:38203585

Expression and antigenicity of recombinant human respiratory syncytial virus glycoproteins having different affinity tags., PMID:28042093

Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution?, PMID:25995258

Polyclonal and monoclonal antibodies specific for the six-helix bundle of the human respiratory syncytial virus fusion glycoprotein as probes of the protein post-fusion conformation., PMID:25010277

Characterization of an experimental vaccine for bovine respiratory syncytial virus., PMID:24828093

Infection-enhancing lipopeptides do not improve intranasal immunization of cotton rats with a delta-G candidate live-attenuated human respiratory syncytial virus vaccine., PMID:23955280

Activation of Toll-like receptor 9 and production of epitope specific antibody by liposome-encapsulated CpG-DNA., PMID:21944255

Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance., PMID:15777938

Comparison of antibodies directed against human respiratory syncytial virus antigens present in two commercial preparations of human immunoglobulins with different neutralizing activities., PMID:15530691

Detection of human respiratory syncytial virus genotype specific antibody responses in infants., PMID:15368511

The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins., PMID:14671094

Synthesis, refolding and protective immune responses of a potential antigen for human Respiratory Syncytial Virus vaccine., PMID:12787448

Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein., PMID:12610153

Structure-antigenicity relationship studies of the central conserved region of human respiratory syncytial virus protein G., PMID:12383117

A model for the generation of multiple A to G transitions in the human respiratory syncytial virus genome: predicted RNA secondary structures as substrates for adenosine deaminases that act on RNA., PMID:12029160

Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein., PMID:11487583

Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV)., PMID:11231898

The C-terminal third of human respiratory syncytial virus attachment (G) protein is partially resistant to protease digestion and is glycosylated in a cell-type-specific manner., PMID:10725417

Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine., PMID:10627529

Expression and characterisation of the ovine respiratory syncytial virus (ORSV) G protein for use as a diagnostic reagent., PMID:10543382

Genetic and antigenic analysis of the G attachment protein of bovine respiratory syncytial virus strains., PMID:9880007

Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein., PMID:9747731

Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants., PMID:9349460

Analysis of the bovine respiratory syncytial virus fusion protein (F) using monoclonal antibodies., PMID:9453129

Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions., PMID:9400970

Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host., PMID:9302749

A subtype-specific peptide-based enzyme immunoassay for detection of antibodies to the G protein of human respiratory syncytial virus is more sensitive than routine serological tests., PMID:9196168

Sequence conservation in the attachment glycoprotein and antigenic diversity among bovine respiratory syncytial virus isolates., PMID:9100323

Antigenic and molecular analyses of the variability of bovine respiratory syncytial virus G glycoprotein., PMID:9018058

Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein., PMID:8661440

Type-specific serologic diagnosis of respiratory syncytial virus infection, based on a synthetic peptide of the attachment protein G., PMID:8699029

Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions., PMID:8551618

The three C-terminal residues of human respiratory syncytial virus G glycoprotein (Long strain) are essential for integrity of multiple epitopes distinguishable by antiidiotypic antibodies., PMID:8546803

Identification of subgroups of bovine respiratory syncytial virus., PMID:1583108

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-HRSV G/Major surface glycoprotein G Antibody (CB002.5) [VVV08501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only